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A novel proton transfer mechanism 
in the SLC11 family of divalent 
metal ion transporters
Jonai Pujol-Giménez, Matthias A. Hediger & Gergely Gyimesi
In humans, the H+-coupled Fe2+ transporter DMT1 (SLC11A2) is essential for proper maintenance 
of iron homeostasis. While X-ray diffraction has recently unveiled the structure of the bacterial 
homologue ScaDMT as a LeuT-fold transporter, the exact mechanism of H+-cotransport has remained 
elusive. Here, we used a combination of molecular dynamics simulations, in silico pKa calculations 
and site-directed mutagenesis, followed by rigorous functional analysis, to discover two previously 
uncharacterized functionally relevant residues in hDMT1 that contribute to H+-coupling. E193 plays a 
central role in proton binding, thereby affecting transport properties and electrogenicity, while N472 
likely coordinates the metal ion, securing an optimally “closed” state of the protein. Our molecular 
dynamics simulations provide insight into how H+-translocation through E193 is allosterically linked to 
intracellular gating, establishing a novel transport mechanism distinct from that of other H+-coupled 
transporters.
Biology and Relevance
Iron is a key element in the metabolism of almost all living organisms, being involved in the transport and stor-
age of oxygen and the catalysis of redox reactions in humans. In human intestine, uptake of ferrous ion (Fe2+) 
from the diet is mediated primarily by the divalent metal ion transporter 1 (DMT1, also SLC11A2)1, expressed 
in the brush border membrane of enterocytes in the duodenum2, 3. Mutations in the SLC11A2 gene can lead to 
microcytic anemia3–6. The availability of DMT1 for oral medication on the luminal side of the intestine makes it 
an interesting drug target for iron overload disorders.
The first mammalian divalent metal ion transporter (DMT1/SLC11A2) was identified from rat and mouse4, 7, 
and was shown to couple the uptake of several transition metal ions (Fe2+, Mn2+ and Cd2+) to the cotransport of 
H+ 7, 8. Interestingly, the stoichiometry of the transported H+:Fe2+ can either be high (~10:1) at low pH, causing a 
large H+ flux that is uncoupled from Fe2+ uptake9 or transport can be H+-independent at high pH10. Additionally, 
the transporter is able to mediate a H+-leak current in absence of substrate10. Analysis of two conserved histi-
dine residues (H267 and H272) in the rat DMT1 transporter pinpointed H272 to be responsible for coupling 
Fe2+ and H+ transport10, but structural evidence suggests that this residue is inaccessible from the extracellular 
medium11–13. In contrast, while the rat H267A mutant had functional characteristics similar to wild-type, the 
corresponding mutation in a prokaryotic homologue was found to cause H+-independent metal ion uptake13. 
Thus, the exact mechanism of coupling and the role of either histidine residue in proton-coupled transport still 
remain elusive.
Structurally, SLC11 transporters belong to the “Amino acid-Polyamine-organoCation” (APC) superfamily11–13, 
containing Na+- and H+-coupled secondary transporters and symporters, some of which are particularly well 
characterized, such as LeuT14–17. In the structure of the H+-coupled transporter ApcT, K158, a residue with a basic 
side-chain located on TMH 5 was shown to be responsible for proton cotransport, extending into the binding 
pocket harboring the Na2 sodium ion in Na+-coupled family members17, 18. In CaiT, which is a H+-independent 
transporter of the same fold family, R262 occupies the location analogous to Na2 in LeuT19. Due to the high esti-
mated pKa of R262, it was proposed that it does not get deprotonated during the transport cycle, but its mutations 
caused lower uptake rates and enabled the stimulation of transport by Na+ 18, 20. These findings suggest that the 
Na2 site in the APC superfamily represents a remarkably conserved and functionally active cation-binding site. 
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Interestingly, such basic residues are missing from the analogous location in SLC11 transporters, suggesting a 
distinct proton binding and transport mechanism.
In our current study, we used a distinctive combination of computational and experimental approaches to sys-
tematically search for residues that could be involved in functional proton binding and transport in divalent metal 
ion transporters, as well as to arrive at a plausible mechanism of proton-coupled transport of SLC11 proteins.
Results
We initially aimed to pinpoint possible proton binding sites where proton binding could have functionally rele-
vant consequences. For this, in silico pKa predictions together with literature data and structural information was 
used, followed by molecular dynamics (MD) simulations.
Estimation of side-chain pKa values. To assess possible residues that might bind protons during the 
transport cycle, in silico pKa estimation was performed for a crystallized prokaryotic homologue, ScaDMT11. 
For these calculations, the co-crystallized Mn2+ ion was retained, which is the native substrate for ScaDMT. The 
pKa of side-chains were estimated in both the presence and the absence of the bound Mn2+ ion, in search for 
side-chain pKa shifts of 1.5 units or more that would favor protonation (Fig. 1A). Some extreme pKa values (e.g. 
D196, H204, K419) for residues that are completely buried in the membrane are likely artefacts arising from the 
use of the simplified continuum dielectric membrane model and the rigid protein structure. Most of the residues 
found with high pKa shifts are on the peripheries of the protein structure, making them less likely to be involved 
in transport. A marked exception is a series of acidic residues in TMH 3, E127, D124 and E117; forming a cluster 
of charged residues with R360, R355 and R356 in TMH 9, and D153 in TMH 4 (Fig. 1B), which has been recently 
suggested to be a possible exit pathway for transported protons13. E127 seemed an interesting candidate for a 
Figure 1. Selected residues based on pKa analysis and the charged cluster around E127. (A) The side-chain pKa 
values of titratable residues were estimated in silico in ScaDMT, both in the presence and absence of the bound 
Mn2+ ion. Residues having a pKa shift of more than 1.5 units from their canonical pKa values in solution are 
shown. Additionally, H233, mutations of which have been shown to cause pH-independent transport in rat 
DMT1, is also included for reference. Residues highlighted in bold are shown in the close-up view on the lower 
half of panel B. (B) All residues on panel A are highlighted in gold on the ScaDMT structure. The close-up view 
of the substrate binding site and a charged residues cluster are shown below. The following regions are color-
coded: TMH 1a stub (truncated N-terminus; orange), TMH 6b (green), TMH 8 (red). TMH 8 is shown as a 
transparent helix in the close-up view.
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proton carrier residue due to its closeness to the substrate binding site (Fig. 1B) and its relative conservedness in 
the PFAM Nramp family (60% Glu and 5% Asp in the family sequence alignment). Three further residues were 
included independently of our pKa estimations in our subsequent computational studies. D49 is a canonical 
metal ion binding residue in the SLC11 family11, calculated to have a relatively high pKa value of 6.77 in absence 
of the Mn2+ ion in ScaDMT (Fig. 1A). The conformation of D49 in the ScaDMT X-ray structure can theoretically 
accept a proton. The conserved histidine residues H228 and H233, shown to cause pH-independent transport 
in different SLC11 transporters10, 13, were also included, despite their low calculated pKa values of 3.26 and 4.84, 
respectively (Fig. 1A), which would predict them less likely to directly bind protons at the operational pH of the 
transporter (5.5–6.5).
Molecular dynamics simulations of various protonated states. Since binding of the cotransported 
ion often induces conformational changes in secondary transporters21–23, we wanted to know whether proton 
binding to any of the four selected residues would lead to functionally relevant conformational changes in the 
protein. To this end, each of the four residues (D49, E127, H228 and H233) was protonated individually in silico 
in ScaDMT and submitted to molecular dynamics (MD) simulations. Conformational changes of the protein 
were compared to a baseline simulation, which will be referred to as the “canonical system” (i.e. Glu, Asp, Lys, 
Arg charged; other residues neutral). Five independent simulations of 50 ns each, starting from the same protein 
conformation were performed for each protonation state. For the MD simulations, due to the absence of either 
Mn2+ and Fe2+ parameters in the force-field used, Cd2+ was used as a metal ion substrate, which has been shown 
to bind to the same site as Mn2+ and to be transported in ScaDMT11.
Quantitating secondary structure content using STRIDE24 shows moderate but detectable helicity loss in TMH 
6b upon the protonation of H228 and to a lesser extent H233 (Fig. 2A, upper panel). Interestingly, larger helicity 
changes were observed in region 325–340, which is located in the middle of TMH 8. Helicity is restored upon 
the protonation of E127, but not any of the three other residues (Fig. 2A, lower panel). A more detailed geomet-
ric analysis based on summing two consecutive backbone dihedral angles (ψi + φi+1, see Methods for details) 
shows abrupt changes in backbone geometry near the highly conserved G327 and Q328 residues in the canonical 
system as well as in several other simulations where either of D49, H228 or H233 is protonated (Fig. 2B). Visual 
inspection shows that the abrupt backbone angle changes are due to the flipping of the peptide bonds, and the 
backbone NH groups establishing hydrogen-bonds with the charged E127 side-chain. This effect was not seen in 
the simulation systems where E127 is protonated.
While residues 325–330 in TMH 8 were modeled as an α-helix in the X-ray structure, they have elevated 
B-factors compared to the rest of TMH 8, suggesting inherent flexibility. In addition, this region is located near 
the Na2 site of the Na+-coupled leucine transporter LeuT (Supplementary Figure S1A), where cation binding is 
involved in transport-related conformational changes17, 25.
As a next step, we tested whether in addition to E127, other residues would contribute to further stabiliz-
ing the structure. To this end, doubly protonated simulation systems were generated, protonating E127 together 
with each of the D49, H228 and H233 side-chains individually. In the doubly protonated systems, the patterns 
of secondary structure loss are similar to but less pronounced than those in the singly protonated systems, and 
the region 325–330 cannot be further stabilized by protonating residues additional to E127 (Supplementary 
Figure S2).
Interestingly, a glutamic acid residue (E112) also exists in TMH 3 of the leucine transporter LeuT at a location 
similar to ScaDMT E127, although in a different register on the helix. However, in similar MD simulations of the 
inward-open LeuT structure (PDB ID: 3TT3), the corresponding region in TMH 8 did not show any instability 
regardless of the protonation state of E112 (Supplementary Figure S1B), suggesting that the proton-dependent 
instability of TMH 8 is a phenomenon specific to ScaDMT, and not a general structural feature of the fold family.
Conformational changes in the intracellular gate region. Divalent metal ion binding site. In some 
of our simulations, a complete octahedral coordination shell around the bound metal ion substrate emerged, 
resembling a “closed” state (Fig. 3A). Compared to the ScaDMT X-ray structure, where only 4 of 6 coordination 
sites are filled, the key rearrangements are the displacement of the Y47 side-chain to fill a previously empty cavity 
between TMHs 6 and 7, lined by L265, Q82 and N229 (Fig. 3B, left panel), while the backbone carbonyl oxygen 
atom of G46 comes close to coordinate the bound metal ion. Importantly, on the opposite side of the binding site, 
Q389, a residue that has not yet been reported to be involved in metal ion binding, approaches to fill the remain-
ing coordination site.
Intracellular gate opening. In 3 out of 5 of the canonical simulations (simulations #3, #4 and #5), and in one 
of the 5 simulations with H228 protonated, we observed that the N-terminal stub of TMH 1a undergoes con-
formational change reminiscent of gate opening, characterized by the extension of the N-terminal end of the 
backbone (Fig. 3C, left panel). The Y47 side-chain leaves its pocket between TMHs 6 and 7, and protrudes toward 
the membrane and the solvent, while the M48 side-chain rotates and extends in the extracellular direction to fill 
a hydrophobic cavity lined by V271, L275, W53, F183, L180 and I176 (Fig. 3B, right panel). Interestingly, in all 
other simulations, including all those where E127 was protonated, the intracellular gate remains in the closed 
conformation throughout the simulations (Fig. 3C, right panel).
Human DMT1. In addition, we also prepared a homology-based model of human DMT1 (Supplementary 
Figure S3A, see also Methods). The estimated pKa values of the analyzed four residues in our model of hDMT1 
show comparable values to ScaDMT (Supplementary Figure S3B), including a large pKa shift for E193, the residue 
corresponding to E127 in ScaDMT. In analogous MD simulations, the human DMT1 structure also exhibited 
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instability in TMH 8 at the location homologous to that observed in ScaDMT (G412, Q413 in hDMT1), which 
was dependent on the protonation state of E193 (Supplementary Figure S3C).
In summary, our MD simulations show that the protonation state of E127/E193 correlates with family-specific 
functionally relevant rearrangements of the protein. Additionally, since we observed that Q389 in ScaDMT 
becomes a coordinating residue of the metal ion substrate, we reasoned that the homologous residue N472 in 
hDMT1 might also take part in metal ion binding. To verify the role of these residues in transport function in the 
human isoform, site-directed in vitro mutagenesis was performed and both substrate uptake and electrophysio-
logical properties of the mutant variants were characterized. For the E193 residue, the conservative Asp and the 
deleterious Ala substitutions were engineered, the E193Q variant was not constructed because the corresponding 
E112Q mutant in the homologous E. coli MntH was shown to have greatly reduced transport activity26. In addi-
tion, the N472A variant of hDMT1 was generated to test the involvement of N472 in substrate binding, while the 
M294C variant served as a positive control of binding site modification, as M294 is known to take part in metal 
ion binding11, 27.
Figure 2. Helicity changes upon protonation in ScaDMT. (A) Time average of helicity of each residue as 
observed in simulations of ScaDMT in various protonation states, quantified using STRIDE24. The indicated 
transmembrane regions were taken from the PDBTM database62. Regions with most differences in helicity are 
shown, which are TMH 6 (top) and TMH 8 (bottom). (B) Helicity changes in each MD trajectory were also 
quantitated by calculating the time average of the sum of dihedral angles ψi + φi+1 along the protein chain. For 
an ideal α-helix, this value is ≈−105°. Large values around 200° correspond to local peptide bond flips.
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Plasma membrane expression and substrate uptake by hDMT1 mutants. Surface biotinylation 
showed that all the generated mutants were properly expressed in the plasma membrane of transfected HEK293 
cells (Fig. 4A and B, expected size 75 kD), although some at lower levels than WT (Fig. 4C). Therefore, in the sub-
sequent experiments using transiently transfected HEK239 cells, all results were normalized to the relative plasma 
membrane surface expression of each mutant.
In subsequent radiolabeled 55Fe2+ experiments, no Fe2+ uptake was observed for M294 and N472 mutants, 
while for the E193D and E193A substitutions, uptake was reduced by ≈45 and 80%, respectively, compared to 
WT (Fig. 4D). Similar results were observed for Cd2+ uptake determined by fluorescence measurements (Fig. 4E). 
Nevertheless, in this case the difference in uptake between WT and E193D was significantly reduced. These 
experiments were conducted at pH 6.5, due to the loss of sensitivity of the Cd2+-sensitive Calcium 5 dye at low 
pH, which may indicate that E193 mutants have a higher affinity for H+ than WT.
Finally, uptake measurements of radiolabeled 55Fe2+ in X. laevis oocytes expressing the proteins under study 
(Fig. 4F) gave similar results as in transfected HEK293 cells, except that the activity of M294C was much higher. 
However, these experiments were conducted at a higher concentration of non-radioactive Fe2+, indicating that 
this substitution decreases the affinity for Fe2+. The lack of functional activity of the N472 mutants points to a key 
role of this residue in the divalent-metal ion binding of DMT1.
Fe2+ and H+ saturation kinetics of E193 and M294 mutants. To understand the impact of each muta-
tion on the functional properties of hDMT1, the pH-dependence and kinetic properties of Fe2+ transport by the 
mutants showing functional activity were determined. Compared to WT, mutants E193D and E193A exhibited 
similar affinity for Fe2+ (Fig. 5A, left panel). However, the vmax for E193D and E193A were ≈54 and 81% lower 
than WT, respectively, in line with previous experiments (Fig. 4E,F). In contrast, the substitution M294C showed 
a drastic decrease in the affinity for Fe2+ (Km = 52.19 µM) (Fig. 5A, right panel; Fig. 5C), confirming the role of 
this residue in metal ion binding of hDMT1.
Figure 3. Metal ion coordination and intracellular gate opening in ScaDMT. (A) A closed coordination shell of 
the metal ion substrate evolved in simulations. Compared to the conformation found in the X-ray structure, the 
backbone carbonyl oxygen of G46 and the side-chain of Q389 fill the remaining two positions in an octahedral 
coordination shell. (B) In the closed conformation (left panel), the side-chain of Y47 fills a cavity between 
TMHs 6 and 7. When gate opening is observed, M48 enters a hydrophobic pocket formed mostly by TMHs 
5 and 7. (C) Intracellular gate opening is observed in 3 of 5 “canonical” simulations (left), but not when E127 
(right) or any of the residues D49 and H233 is protonated. For clarity, the right panel shows only the results 
of simulations where E127 was protonated. Gate opening is also observed in 1 of 5 simulations where H228 is 
protonated (not shown in figure), evolving into a conformation similar to that of canonical #3 and #5.
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As for pH-dependence, the E193D and E193A mutants showed a ≈10-fold increase in the apparent H+-affinity 
compared to WT (Km = 1.05 µM) (Fig. 5B). For the M294C mutant, Fe2+ uptake was only measurable at pH 5.5, 
and thus, it was not possible to determine the H+ saturation kinetics. These findings (summarized in Fig. 5C) are 
in agreement with the predicted role of residue E193 in the H+-hDMT1 interaction.
Electrophysiological characterization of hDMT1 mutants. Fe2+ evoked inward currents in oocytes 
expressing WT, E193D and E193A (Fig. 6A) but not M294C, M294Q, N472Q, N472A and in non-injected 
oocytes (data not shown). Compared to WT, the Imax recorded for E193D and E193A was ≈40 and 95% lower, 
Figure 4. Plasma membrane expression and substrate uptake by hDMT1 and mutants. (A) Representative blot 
of the plasma membrane expression of hDMT1 and the indicated mutants in transiently transfected HEK293 
cells. Expression was assessed by immunoblotting of the labeled plasma membrane protein by sulfo-NHS-
LC-biotin isolated on streptavidin agarose beds. (B) Biotin was used as equal loading control (the absence of 
actin confirms the purity of the membrane fraction). (C) Mean plasma membrane expression of each protein 
was obtained by averaging the optical density (OD) of the corresponding bands obtained form 3 independent 
blots. These values were normalized to the OD of its corresponding loading control. (D) Radiolabeled iron 
uptake (55Fe2+) (1 μM) by HEK293 cells expressing the indicated proteins was measured in uptake buffer at 
pH 5.5 after 15 min incubation. (E) Cd2+ (1 μM) transport activity by HEK293 cells expressing the indicated 
proteins. Changes of fluorescence intensity of Calcium-5-dye were continuously recorded at extracellular 
pH 6.5 during 10 min incubation with Cd2+ and the uptake was determined as the area under the curve. The 
radioactive iron uptake (D) and the fluorescence intensity (E) of each isoform were corrected for the unspecific 
uptake by empty vector transfected HEK293 cells. Results from 3 independent experiments were normalized 
to Fe2+ (D) (N = 41–56) or Cd2+ (E) (N = 18–24) uptake by hDMT1 WT, corrected according to their plasma 
membrane expression and represented as the mean ± S.D. (F) Uptake of 20 μM 55Fe2+ (pH 5.5, 10 min) in 
oocytes expressing hDMT1 and the indicated mutants. Uptake values were corrected for unspecific iron uptake 
in non-injected oocytes. Data from 6 different batch of oocytes were normalized to the mean iron uptake by 
hDMT1 WT (0.83 ± 0.3 to 2.79 ± 0.4 pmol∙oocyte−1∙min−1) and are represented as the mean ± S.D. (25 to 74 
oocytes). Statistical differences (D–F) were assessed using T-test (Fe2+-uptake by hDMT1 WT vs each mutant); 
ns p > 0.05; *p < 0.05; **p < 0.01; ***p < 0.001.
www.nature.com/scientificreports/
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respectively. Nevertheless, for WT and E193 mutants, Fe2+-evoked currents followed a curvilinear relationship 
with voltage, which increased with the hyperpolarization of the membrane as previously described for hDMT128.
Pre-steady state currents have been previously reported for rat and human DMT110, 28. Compared to WT, the 
pre-steady state currents for E193D (Fig. 6B) showed ≈45% lower maximal charge transfer (Qmax), but similar 
midpoint (V0.5 ≈+60 mV), apparent valence (z) of the movable charge of ≈−2 and turnover rate of ≈25 s−1 
(Fig. 6C). The number of functional transporters (NT) was calculated to be ≈40% lower than WT, which also 
explains the observed ≈45% reduction in Imax and Qmax. In contrast, the substitution E193A did not show any 
pre-steady state currents, which might indicate that the negative charge of the glutamic acid, also present in the 
E193D mutant, is essential for this property of the transporter. Alternatively, it is possible that our setup was not 
sensitive enough to detect pre-steady state currents of E193A.
Electrophysiological properties of the Fe2+ and H+ saturation kinetics of the E193D mutant. To 
clarify whether the differences observed between WT and the E193D variant are merely due to reduced expres-
sion or mechanistic changes in the transporter itself, saturation kinetics of the electrophysiological properties for 
both Fe2+ and H+ were analyzed.
The Fe2+-induced steady-state currents were saturable with Fe2+, having a half-maximal (K0.5) Fe2+ concen-
tration for WT and E193D of 2.9 and 1.9 µM, respectively (Fig. 7A). The affinity obtained for WT resembles the 
one determined in HEK cells (Fig. 5A), while for E193D the K0.5 for Fe2+ is slightly higher. Plotting the K0.5-V 
relationship (Fig. 7B) showed that WT hDMT1 was modestly voltage-dependent, while E193D showed similar 
behavior to WT within the range of −150 to −50 mV, and became more voltage-dependent above −50 mV, with 
K0.5 values that increase with depolarization, reaching WT values at −10 mV.
Measuring Fe2+-evoked currents at different pH values showed that WT was not completely saturable with 
H+, in contrast, the E193D mutant was saturated already at pH 6.5, as also reflected by the highly significant 
decrease in the apparent K0.5 for H+ (≈0.11 µM) (Fig. 7C), being in agreement with our previous results (Fig. 5B 
Figure 5. Fe2+ and H+ saturation kinetics of WT hDMT1 and E193 and M294 mutants in stably transfected 
HEK293 cells. (A) Representative experiments of 55Fe2+ uptake kinetics by hDMT1 and E193 and M294 
mutants as a function of increasing Fe2+ concentrations (0.1–20 µM). (B) Representative experiment of 55Fe2+ 
uptake kinetics by hDMT1 and E193 mutants as a function of increasing H+ concentration (pH 5.5–7.5). 
For each concentration of the substrate, the background uptake measured for the empty vector transfected 
HEK control cells was subtracted. Uptake values were also corrected according to their plasma membrane 
expression and represented as the mean ± S.D. A Michaelis-Menten equation (connecting lines) was fit to the 
data and the obtained kinetic parameters are summarized in a table below each graph. (C) Summary table of the 
apparent affinities for Fe2+ and H+ of hDMT1 and the indicated mutants. Km values were calculated from 2–3 
independent experiments and are presented as means ± S.D.
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Figure 6. Steady-state and pre-steady state currents for WT hDMT1 and E193 mutants expressed in X. 
laevis oocytes. (A) Current-voltage relationship (Vh = −50 mV; pH 5.5; 20 μM Fe2+). (B) Q/Vm relationship 
(Vh = −50 mV; pH 5.5). Pre-steady state currents were integrated with time to obtain the charge Q and depicted 
at test potentials (Vt) ranging from −110 mV to +90 mV. Corresponding curves on panels A and B were 
recorded in the same oocytes, which were obtained from the same batch. Similar results were observed in 
7–10 oocytes from 3 different batches. (C) The maximal current evoked by 20 µM Fe2+ (Fig. 1A) was taken as 
Imax. Pre-steady state parameters (Qmax, z, V0.5 and r2) were derived from data in panel B by fitting a Boltzmann 
equation (connecting lines). The number of functional transporters (NT) expressed in the plasma membrane 
was determined as NT = Qmax/z∙e (e = 1.6 × 10−19 C). Turnover rate was determined as −Imax/Qmax.
Figure 7. Fe2+ and H+ saturation kinetics of the steady-state currents of hDMT1 and E193D mutant expressed 
in X. laevis oocytes. (A) Representative experiment of Fe2+-evoked steady-state currents (Vh = −50 mV; 
Vt = −70 mV; pH 5.5) as a function of [Fe2+]. (B) Fe2+-transport K0.5 as a function of membrane potential (Vm), 
each K0.5 value corresponds to the mean ± S.D. calculated from 4–5 oocytes obtained from 2 different batches. 
(C) Representative experiment of Fe2+-evoked steady-state currents (Vh = −50 mV; Vt = −70 mV; 20 µM) as a 
function of [H+]. (D) Fe2+-transport K0.5 as a function of membrane potential (Vm), each K0.5 value corresponds 
to the mean ± S.D. calculated from 4–5 oocytes obtained from 2 different batches. Kinetic parameters of Fe2+-
transport of the representative panels A and C were calculated by fitting a 4-parameter sigmoidal equation 
(connecting lines) to the data and are summarized below the corresponding graph.
www.nature.com/scientificreports/
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and C). Regarding the K0.5-V relationship (Fig. 7D), WT hDMT1 showed a moderate increase in the apparent K0.5 
for H+ with hyperpolarization. Strikingly, in E193D it was completely voltage-independent, indicating that the 
ion well effect10 is lost, likely because the ion binding site is more exposed. Altogether these results reflect a change 
in the transport mechanism of the E193D mutant, probably due to the mutagenesis-induced conformational 
changes of the protein, rather than protein expression.
Regarding the Hill coefficient (NH) for H+ and Fe2+ (Fig. 7A and C), which reflects the cooperativity among 
multiple ligand-binding sites, it was in both cases ≈1.5 and didn’t show voltage-dependence (data not shown), 
which suggests that there is no change in the stoichiometry of the transport process due to the mutation, or at 
least, in the number of allosteric binding sites. In line with this observation, the H+-driven Fe2+-induced currents 
and the Fe2+-transport by the E193D mutant (Figs 4F and 6A, respectively) were reduced to the same extent, 
which further supports the idea of an unaltered stoichiometry due to the mutation.
Electrophysiological characterization of the H+-leak mediated by E193 mutants. Since the 
E193 mutants significantly modified the interaction of DMT1 with H+, the impact of this mutation on the 
DMT1-mediated H+-leak10, 28 in the absence of metal ion was studied. For both WT and E193 mutants, H+-leak 
currents followed a curvilinear relationship with voltage, and increased with the hyperpolarization of the mem-
brane (Supplementary Figure S4A). I-V relationships for WT and E193D were almost identical, while currents 
in the E193A mutant were similar but much lower. The H+-leak currents for both WT and E193D mutant were 
saturable, with similar kinetic parameters and voltage-dependence (Supplementary Figures S4B and C), but for 
E193A, they were only measurable at the lowest pH, so the kinetic parameters could not be determined. These 
results indicate that the position E193 does not seem to play role in the H+-leak through hDMT1. Nevertheless, 
since the H+-leak currents were significantly reduced with the substitution E193A, this could reflect the overall 
loss of activity of this variant or conversely the relevance of the negative charge, present in both WT and E193D 
mutant, to this particular feature of the transporter.
Dependence of pre-steady state currents on [H+]. To better understand the role of the position E193 
in the H+-DMT1 interaction, the dependence of the pre-steady state currents on external H+ concentration was 
studied. For the WT, the maximal charge transfer (Qmax) increased linearly with increasing external concen-
tration of H+ (Fig. 8A and C), and the voltage for maximal charge midpoint (V0.5) decreased with decreasing 
[H+] until the Qmax switched to negative values at pH 6.5 (Fig. 8A and D). Interestingly, contrary to WT, for 
the E193D mutant the Qmax increased linearly with the reduction of the external concentration of H+ until pH 
6 (Fig. 8B and C) and showed positive values for the complete pH range tested (Fig. 8C). Conversely, similar to 
WT, the voltage for maximal charge midpoint (V0.5) decreased with decreasing external concentration of H+ 
(Fig. 8D). Nevertheless, in contrast to WT, the V0.5 did not start to increase again at pH 7, indicating a different 
voltage-dependence. Pre-steady state currents of DMT1 are consequence of the dissociation of the H+ from the 
transporter and reorientation of the empty charged protein within the plasma membrane. Therefore, the differ-
ence observed between WT and E193D might reflect a different arrangement of the H+ binding site, additionally, 
the decrease of the Qmax values with the increase of [H+] observed for the E193D mutant could be consequence 
of a slow dissociation of the H+-DMT1 complex due to the high affinity of the mutant for H+ (K0.5 ≈ 0.1 µM).
Accessible rotameric states. Overall, the altered H+-affinity, voltage-dependence and the drastic change 
in the pre-steady state currents of E193 mutants prompted us to assess protonation-dependent changes in 
the microscopic conformation of the E127 side-chain in our ScaDMT simulations in order to reveal possible 
proton-transport mechanisms.
Analysis of the accessible rotameric states of the E127 side-chain, as described by the χ1 and χ2 dihedral 
angles, during the MD simulation trajectories shows four major conformational clusters in the canonical system 
(marked #1-#4, Fig. 9C). Clusters #1 and #2 correspond to a conformation that is oriented toward a solvated 
vestibule accessible from the intracellular side. In contrast, conformations in clusters #3 and #4 are expected to 
be in contact with the extracellular medium through the substrate binding site (Fig. 9A). Protonating D49 or 
H233 does not significantly change the pattern of accessible states (data not shown). However, protonating H228 
enhances the transitions between clusters #1 and #3, possibly indicating a lowered free energy barrier between 
these two states (Fig. 9C, right panel). When E127 is protonated, clusters #3 and #4 become completely inac-
cessible, indicating that the preferred orientation of the protonated E127 side-chain is toward the intracellular 
medium (Fig. 9D, left panel). In addition, a new distinct cluster, marked as cluster #5, appears, corresponding to 
a conformation where the added proton is pointing “upwards” toward the extracellular side (Fig. 9B). Transitions 
between clusters #1, #2 and #5 are also enhanced by the additional protonation of H228 (Fig. 9D, right panel).
Additionally, pKa estimation of the E127 side-chain in the centroid conformations of the four clusters in the 
canonical simulations reveals a higher pKa value in clusters #3 and #4 (7.96 and 6.20, respectively) compared to 
clusters #1 and #2 (4.40 and 3.32, respectively), indicating that proton binding is more likely in the extracellu-
larly accessible conformational clusters (Fig. 9A). Taken together, these results hint at a possible inward-rectified 
mechanism of proton transport by the E127 side-chain.
Propagation of signal for gate opening. Since no systematic changes in the hydrogen bonding pattern 
could be observed between closed and open states of the intracellular gate in our MD simulations, the signal 
for gate opening upon proton loss is likely not mediated by hydrogen bonds. Alternatively, to test whether the 
signal is the loss of the electrostatic charge of the proton itself, we prepared an unphysical simulation system of 
ScaDMT carrying an E127 side-chain that is deprotonated but uncharged. In the resulting five MD simulations 
of this system, no loss of helicity throughout TMH 8 (Supplementary Figure S5A) and a closed intracellular 
gate were observed, similarly to the protonated E127 system. However, the neutral E127 side-chain displayed 
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Figure 8. pH-dependence of the pre-steady state currents of hDMT1 and E193D mutant expressed in X. laevis 
oocytes. Dependence of the Q/Vm relationship of hDMT1 WT (A) and E193D (B) mutant on [H+]. Pre-steady 
state currents were integrated with time to obtain the charge Q, and depicted at test potentials Vt (−10 mV to 
+90 mV) from the holding potential Vh = −50 mV at the indicated pH values. A Boltzmann equation was fit 
(connecting lines) to data in panels A and B to obtain the kinetic parameters (Qmax and V0.5). (C) Dependence of 
Qmax on [H+]. For each individual oocyte, Qmax values were normalized to the Qmax determined at pH 5.5 (WT 
Qmax 81.6 to 97.7 nC; E193D Qmax 41.55 to 81.6 nC). Represented Qmax values correspond to the mean ± S.D. 
calculated from 5–13 oocytes obtained from 4 different batches. (D) V0.5 as a function of [H+], each V0.5 value 
corresponds to the mean ± S.D. calculated from 3–10 oocytes obtained from 4 different batches. Connecting 
lines in panels C and D were drawn only for illustration purposes.
Figure 9. Accessible rotameric states of E127 in ScaDMT. Cluster centroid conformations of the E127 side-
chain observed in the “canonical” simulations (A) and when E127 is protonated (B). Accessibility of the 
extracellular and intracellular vestibule, cluster numbers, the χ1 and χ2 angles of the side-chain, and side-chain 
pKa values in each conformation are indicated. The five simulation trajectories are shown color-coded for each 
protonation state (C, D), mapped into the space of the χ1-χ2 dihedral angles.
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marked flexibility and could access all of the states of either the deprotonated or the protonated E127 side-chain 
(Supplementary Figure S5B). Thus, proton release likely triggers gate opening directly through Coulombic inter-
actions between the E127 side-chain and the gate, while the presence of the H+ ion, and not only its charge is 
required to stabilize the E127 side-chain in the low-pKa orientation.
E193D and E193A variants of hDMT1. To establish a link between our experimental results of the 
hDMT1 E193 mutants and our computer simulations, five simulations for each of the protonated and depro-
tonated E127D (ScaDMT) and the E127A variant were set up, which all exhibited a highly stable TMH 8 
(Supplementary Figure S6A, left panel) and no observable intracellular gate opening. The results were repro-
duced in simulations of the human DMT1 model carrying the corresponding E193D and E193A mutations 
(Supplementary Figure S6A, right panel). Conformational analysis showed that only a single conformational 
cluster is present for the D127/D193 side-chain in E127D/E193D mutants, which is facing the intracellular ves-
tibule (Supplementary Figure S6B). The calculated pKa values of the Asp side-chains in these conformations 
were between those calculated for the extra- and intracellularly facing conformations of E127 in ScaDMT, being 
5.33 and 4.60 pH units for D127 in ScaDMT and D193 in hDMT1, respectively (Supplementary Figure S6B). We 
propose that these changes in conformational stability and proton affinity are linked to the observed changes 
in pre-steady state charge movements and experimental proton affinity between the wild-type and the E193D 
variant.
Discussion
Applying a combination of computational and experimental methods, our efforts have highlighted two novel 
residues as important determinants of function.
Based on our MD simulations, Q389 in ScaDMT (N472 in hDMT1) is a novel substrate-binding residue in 
divalent metal ion transporters. Mutagenesis experiments confirmed that altering the length of N472 in hDMT1 
(N472Q) and removing the side-chain altogether (N472A) has detrimental effects on iron uptake, similarly to 
M294Q. In contrast, the M294C variant retains metal ion binding, although with significantly decreased affinity, 
reinforcing its role in substrate binding11, 27, while not affecting transition metal selectivity, as our radioactive 
55Fe2+ and Cd2+-sensitive fluorescence uptake experiments suggest. A comparison of inward- and outward-open 
states of the leucine transporter LeuT (PDB IDs: 3TT3, 3TT1) suggests that coordination of the substrate by 
Q389/N472 might be the step required for closure of the substrate binding site on the extracellular side, drawing 
TMH 10 and TMH 1b close to each other.
While the unusually high pKa value of the E127/E193 side-chain and the significant stabilizing effect of its pro-
tonation alone might argue in favor of E127/E193 being constantly protonated, mutant variants at position 193 in 
hDMT1 show altered proton binding as well as transport properties, indicating that proton binding is dynamic at 
this position and is also affecting transport. In addition, we calculate a significantly lower pKa value for E127/E193 
for conformations in our MD simulations (Fig. 9A) compared to the crystallized conformation. Due to the pres-
ence of the lipid bilayer and room temperature conditions, the MD simulations might reflect the physiological 
state of the protein better than the crystallized conformation, and thus the decreased pKa values would support 
the presence of conformations where proton dissociation from E127/E193 can happen. Since protons are fixed 
to the protein in MD simulations, we cannot observe proton dissociation during our simulations. However, this 
does not rule out the possibility that proton hopping from E127/E193 to a nearby side-chain or water molecule 
would be energetically favorable.
There are several pieces of evidence suggesting that the E193D variant has increased binding affinity for pro-
tons. Apart from higher apparent affinity in measurements of uptake transport kinetics (Fig. 5B and C), the 
E193D variant showed saturation of current already at pH 6.5 (Fig. 7C), likely because the protein cannot medi-
ate higher transport-dependent uncoupled currents. In line with these findings, we found a highly significant 
increase of Qmax compared to WT at the lowest H+ concentration tested (pH 7.7), indicating that negatively 
charged residues responsible to bind H+ are mostly outward-facing in E193D, since the reorientation of the 
empty transporter is expected to be the main cause of the pre-steady state currents under high pH conditions. 
Interestingly, at high pH (7.7–7.0) the Qmax values increased with [H+] (Fig. 8C), which is the expected behavior 
for Na+-coupled symporters such as SGLT129, corresponding to the ability of the transporter being able to bind 
and unbind more ions as they become available. However, at lower pH (pH 6.5–5.2), Qmax gradually decreased 
with the increase of [H+], reminiscent of inhibitor phlorizin binding to SGLT1, which has been shown to lock 
the transporter in an electroneutral state29, 30. Similarly, we speculate that increasing proton concentrations could 
lock the E193D variant in an occluded, uncharged conformation. Hindered loss of proton due to higher affinity 
in turn would affect intracellular gate opening, as suggested by our molecular dynamics simulations. This idea is 
supported by our pKa calculations (Supplementary Figure S6B) showing a lower pKa for D193 than E193 in an 
inward-facing orientation, and the fact that the E193D mutant shows a 10-fold increase in K0.5 for H+, but dimin-
ished vmax and Imax parameters (Figs 5C and 6C). Additionally, the reduced flexibility of the D193 side-chain as 
seen in our rotamer analysis could explain the voltage independence of the apparent H+ binding affinity (K0.5) 
and the altered pre-steady state current pattern by removing the rate-limiting step of side-chain reorientation.
Strikingly, the E193A variant under our hands is able to mediate iron uptake that is about 30% of wild-type 
with a significantly reduced current in our electrophysiology setup. Since most of the transport-related current in 
wild-type hDMT1 is expected to be transport-dependent uncoupled proton currents9, 10, it is likely that E193A is 
unable to host such uncoupled currents. The fact that we still see iron transport is nevertheless compatible with 
previous results showing that iron uptake is possible without proton transport10. Interestingly, proton concentra-
tion can still stimulate iron transport of the E193A mutant to some extent between pH 6–7.5 (Fig. 5B). We believe 
this can be attributed to other protonatable residues in hDMT1 that could contribute to its transport properties, 
for example, by stabilizing the protein structure, even though these bound protons might not themselves be 
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transported. Residues in Fig. 1A that have a high pKa shift and lie outside of the transmembrane region could be 
potential examples, as many of them are also conserved in human DMT1.
A possible mechanism of how proton binding to E193 could affect substrate transport in hDMT1 is suggested 
by our molecular dynamics simulations. Our pKa estimations indicate that compared to the other studied residues 
(D49, H228 and H233), the E127 residue is the most likely proton acceptor near the substrate binding site. The 
presence of the proton helps lock the E127 side-chain in a low-pKa conformation to facilitate the dissociation 
of the proton. We suggest that allosteric coupling between the E127/E193 side-chain and the intracellular gate 
is established through Coulombic interactions, and the trigger signal for gate opening is the loss of the charge 
from the E127 side-chain. The cluster of charged residues (D153, R360, D124 in ScaDMT; D221, R445, D190 in 
hDMT1) constitutes a possible exit pathway of the proton into the water-solvated intracellular vestibule. After 
proton dissociation, the local unwinding of TMH 8 might be necessary to sterically aid the reorientation of the 
E127/E193 side-chain into a high-pKa proton-accepting state. The overall suggested mechanism is summarized 
in Fig. 10. It should be noted that there are still several details of the proposed mechanism that need to be investi-
gated, including how proton dissociation from the E127/E193 side-chain happens under transporting conditions, 
and which molecular events trigger this step. Therefore, further experiments will be conducted in the future to 
clarify these open questions.
While we provide a plausible mechanism of proton-coupled transport, we cannot rule out the possibility that 
other residues are also involved in proton coupling. In particular, protonation of H228 in ScaDMT simulations is 
able to trigger intracellular gate opening, however, only when E127 is deprotonated, which is unlikely, due to the 
consistently high side-chain pKa of E127 and the stabilizing effect of its protonation on TMH 8. Intolerance of the 
Figure 10. Proposed mechanistic model of the transport cycle of hDMT1. Transmembrane helices are shown 
color-coded: TMH 1a (orange), TMH 1b (dark blue), TMH 3 (light blue), TMH 8 (red), with TMH 3 located 
behind TMH 8. Divalent metal ion substrate is shown as yellow disc; proton as black disc. Water-accessible 
vestibules are indicated with dashed lines. Arrows indicate movements of components. (A) Substrate binding 
happens in the high-pKa state of E193, likely in an ordered manner. After substrates bind, a conformational 
switch is proposed to occur, bringing the protein into an inward-open-like occluded state, where E193 flips 
over to a low-pKa conformation. (B) In the low-pKa conformation, proton dissociation occurs possibly along 
a pathway flanked by D221, D190 and R445 (D153, D124 and R360 in ScaDMT, respectively). (C) The loss of 
the proton induces three key conformational changes: the partial unwinding of TMH 8 near residues 410–417 
(corresponding to residues 325–330 in ScaDMT), increased flexibility of the E193 side-chain and the opening 
of the intracellular gate. At this point, substrate-dependent uncoupled proton leak could happen at high proton 
concentrations by jumping back to state A, if transition to state D is slow enough. (D) After gate opening, the 
metal ion substrate is solvated and leaves the binding site. (E) Local helix unwinding in TMH 8 facilitates the 
recovery of E193 into the high-pKa state, and closure of the intracellular gate happens. (F) The high-affinity 
outward-open state is recovered. Additionally, this mechanism also allows for the uniport of metal ions in the 
absence of protons through cycle A-D-E-F-A.
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structure to a protonated H228 side-chain might be due to the low proton affinity of the protein conformation 
captured in the crystal. However, protonation of H228 in MD simulations with ScaDMT affects the conformation 
of E127, indicating intimate cross-talk between the two residues (Fig. 9C and D). Finally, it should be taken into 
account that the R356 residue in ScaDMT, proposed to be part of the proton exit pathway (Fig. 1B), is not con-
served in human DMT1. Therefore, we expect species-specific differences between the role and extent of E127/
E193-mediated proton transport and also the transport mechanisms themselves.
In summary, our current work provides the first mechanistic insight into the proton coupling and transport 
mechanism of divalent metal ion transporters. A previously uncharacterized residue, E193 in hDMT1, is pro-
posed to translocate protons in an inward-rectified manner by alternating contact with the solvent on each side 
of the membrane bilayer. This mechanism is unique and not akin to currently known proton cotransport mech-
anisms in similar APC-fold transporters. Our study also complements the X-ray structure by identifying N472, 
which is predicted to be a novel metal ion substrate binding residue in SLC11 divalent metal ion transporters.
Methods
pKa calculations. The side-chain pKa values were calculated in two steps based on similar work on the leu-
cine transporter LeuT31. First, PROPKA 3.132, 33 was used to estimate side-chain pKa as if the protein was solvated 
in water, second, APBSmem34 was used to calculate the pKa shift due to the presence of the membrane bilayer. 
The calculation was performed both in the presence and the absence of the bound Mn2+ ion in ScaDMT. For 
PROPKA 3.1, default options were used. For APBSmem, the PARSE force-field was used, 0.1 M monovalent 
counterions with 2.0 Å radius, 298.15 K temperature, and the dielectric constants of protein, solvent, membrane 
and headgroup were set to 2.0, 80.0, 2.0 and 80.0, respectively. Membrane and headgroup thickness of 42.0 Å and 
9.0 Å were used, respectively, with the membrane bottom at −21.0 Å. Calculations were performed with the Npbe 
method, Spl2 charge model and three-step grid refinement as described previously for LeuT31.
MD simulations and trajectory analysis. Coordinates of the inward-open ScaDMT were taken from 
the Orientations of Proteins in Membranes database35 (PDB ID: 4WGW). The co-crystallized manganese ion 
(Mn2+) was changed to cadmium (Cd2+) due to the lack of parameters for Mn2+ in the CHARMM36 force-field. 
The choice of Cd2+ is supported by the fact that it is a substrate for both ScaDMT and hDMT18, 11, 36. The pro-
tein was embedded into a POPE (palmitoyl-oleoyl-phosphatidyl-ethanolamine) bilayer for ScaDMT, or POPC 
(palmitoyl-oleoyl-phosphatidyl-choline) bilayer for hDMT1; water, neutralizing ions (Cl−) and 150 mM NaCl 
using CHARMM-GUI37–40 with default options. The protein chain N-terminus was capped by acetylation. 
Simulations were performed using the CHARMM36 force-field41, 42 in an NPγT ensemble at zero surface tension, 
303.15 K temperature and 2 fs step size using NAMD 2.943 on UBELIX (http://www.id.unibe.ch/hpc), the HPC 
cluster at the University of Bern. For analysis, STRIDE24 as implemented in VMD 1.9.244, and MDAnalysis45, 46 
were used, along with custom-written scripts. Figures were prepared using PyMOL 1.8.2.147. For backbone dihe-
dral angle analysis, the sum ψi + φi+1 of the ψ backbone dihedral angle of residue i and the φi+1 of residue i + 1 was 
calculated for each residue. For an ideal α-helix, this value is around ≈−105°.
Human DMT1 model generation. Sequence alignment between S. capitis DMT (ScaDMT) and human 
DMT1 (UniProt ID: P49281–3, 1A-IRE (+) isoform) were generated using the PSI-COFFEE48, 49 service at 
Vital-IT (http://tcoffee.vital-it.ch/apps/tcoffee/do:psicoffee), with the following modifications: (i) K354-K376 in 
hDMT1 was modeled without a template; (ii) D377-A382 in hDMT1 was aligned with G292-L297 in ScaDMT; 
(iii) Y522 in hDMT1 was aligned with Y439 in ScaDMT. Residues 111–522 of hDMT1 were modeled using 
MODELLER 9.1450–53. Secondary structure restraints for α-helix on residues 357–363 were introduced based on 
consensus predictions by JPred454, Jufo9D55 and PSIPRED 3.356, 57 predictions. The sequence identity between 
ScaDMT and hDMT1 was 35.3%, reinforcing the feasibility of model construction. The best scoring model 
according to MODELLER objective function was chosen for subsequent studies. For MD simulations, the human 
DMT1 model was embedded in POPC (palmitoyl-oleoyl-phosphatidyl-choline) bilayer using CHARMM-GUI 
as described for ScaDMT. During the simulations, the RMSD (root mean square deviation) of Cα atoms from the 
initial model coordinates did not exceed 4 Å excluding the larger extracellular loop (residues 352–378), indicating 
stability of the constructed model.
Materials
All chemicals and reagents were purchased from Sigma-Aldrich except where specified.
Site-directed mutagenesis of human DMT1. hDMT1 mutants were generated by PCR amplification 
of WT hDMT1 using primers (Table 1) designed to introduce single amino-acid substitutions at positions E193, 
M294 and N472. For the experiments using transiently transfected human cells our previously published pIRES2 
(DsRed)-hDMT1 (isoform 1A-IRE (+)) construct36 was used as DNA template for PCR, while for the exper-
iments using microinjected X. laevis oocytes, the WT hDMT1 (isoform 1A-IRE (+)) was subcloned into the 
Pol1 vector58 and used as template for PCR. PCR products were digested with Dpn I (New England Biolabs 
(NEB)), which cleaves at methylated sites, allowing to digest specifically the cDNA templates but not the PCR 
products. XL1-Blue MRF super competent cells (Agilent technologies) were transformed with the cDNA encod-
ing the mutants by heat-shock method and selected on LB-agar plates containing 100 µg/mL ampicillin (pIRES 
DsRed constructs) or 30 µg/mL kanamycin (Pol1 constructs). Mutations at desired positions were verified by 
DNA sequencing of the final constructs (Mycrosinth AG, Balgach, Switzerland) using specific primers (Table 1).
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Cell culture and transient transfection of HEK293 cells. HEK293 cells, obtained from American Type 
Culture Collection (ATCC, Manassas, VA), were plated on poly-D-lysine coated 6-well or 96-well plates and 
maintained in Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen) supplemented with 10% fetal bovine 
serum (FBS) and 100 units/ml penicillin/streptomycin mixtures (Invitrogen). Cells were cultured in an incubator 
at 37 °C in a humidified atmosphere of 95% air and 5% CO2. Next day, cells were transfected with the desired 
cDNA and Lipofectamine 2000 (Invitrogen), as described in the manufacturer’s protocol. Functional studies and 
expression level determinations were performed 24 hours after transfection.
Expression of wild-type and mutant human DMT1 in X. laevis oocytes. Pol1 vector containing 
the desired hDMT1 variant under the T7 promoter was linearized with Nhe I (NEB), and the cRNA was syn-
thesized in vitro using the mMESSAGE mMACHINE T7 kit (Ambion). Defolliculated stage V-VI oocytes were 
micro-injected with ≈20 ng of each cRNA under study, and maintained in modified Barth’s medium (88 mM 
NaCl, 1 mM KCl, 2.4 mM NaHCO3, 0.82 mM MgSO4, 0.66 mM NaNO3, 0.75 mM CaCl2, 10 mM HEPES) supple-
mented with antibiotics. Functional studies were performed 3–5 days after micro-injection.
Cell surface biotinylation and immunoblotting. These experiments were conducted as previously 
described59. Briefly, HEK293 cells were seeded in 6-well plates and transfected as above mentioned. After 24 hours, 
the cells were rinsed with PBS and incubated with 1.5 mg/mL sulfo-NHS-SS-biotin for 1 hour at 4 °C. After the 
labelling of the surface proteins with biotin, cells were washed with quenching buffer (standard phosphate buffers 
saline (PBS) buffer supplemented with 1 mM MgCl2, 0.1 mM CaCl2, and 100 mM glycine) and then rinsed once 
with PBS. Next, cells were lysed in radioimmunoprecipitation assay buffer (RIPA) (150 mM NaCl, 5 mM EDTA, 
1% Triton X-100, 0.5% deoxycholate, 0.1% SDS, 50 mM Tris-HCl, pH 7.4) containing fresh protease inhibitor 
cocktail (Roche), and lysates were cleared by centrifugation. Cell lysates of equivalent amounts of protein were 
equilibrated overnight with streptavidin-agarose beads at 4 °C. Next day, beads were washed and recovered by 
centrifugation. Biotinylated protein was then released by heating to 95 °C with 2X Laemmli buffer, resolved on 
SDS-polyacrylamide gels, and transferred onto Immobilion-P membrane blots (Millipore). After sequential 
incubation of the blots with primary and secondary antibodies, proteins were revealed by enhanced chemilu-
minescence method (ECL). Primary antibodies were obtained from the following sources: mouse monoclonal 
human DMT1 (1:4000 dilution) (Abnova, Luzern, Switzerland) and rabbit polyclonal anti-actin (1:1000 dilution) 
(Santa Cruz Biotechnology). Secondary antibodies were obtained from the following sources: HRP-conjugated 
goat anti-mouse IgG (1:4000) (Bio-Rad) and goat anti-rabbit IgG (1:20000) (Promega). As a loading control, all 
biotinylated proteins were visualized with Avidin-HRP conjugate (Bio-Rad). To establish the relative expression 
levels of the different proteins, densitometry determination was performed using the National Institutes of Health 
software, ImageJ60.
Radiotracer iron uptake. HEK293 cells were seeded in clear bottom, white-well, poly-D-lysine coated 
96-well plates and transfected as described above. After 24 hours, the growth medium was removed and the cells 
were washed 3 times with uptake buffer (140 mM NaCl, 2.5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 1.2 mM K2HPO4, 
100 mM glucose, 5 mM HEPES, 5 mM MES, pH 7.4). To measure the Fe2+ uptake, 100 µl of uptake buffer (pH 
5.5) supplemented with the desired concentration of non-radioactive Fe2+, 1 mM ascorbic acid and 0.5 µCi/mL 
radioactive 55Fe2+ iron (American Radiolabeled Chemicals, St. Louis, MO, USA) was added into each well. The 
assay was performed at room temperature over 15 minutes, and the uptake was terminated by washing the plates 3 
times with ice cold uptake buffer using an ELx405 microplate washer (BioTek instruments, Luzern, Switzerland). 
Then, 100 µL of Microscint 20 (PerkinElmer) was added to each well and incubated during 1 hour at room tem-
perature under constant agitation. Radioactive 55Fe2+ iron uptake was determined using a TopCount Microplate 
Mutagenesis primers Oligonucleotide sequence
E193D 5′-GGC TCA GAC ATG CAA GAC GTC ATT GGC TCA GCC-3′
E193A 5′-GGC TCA GAC ATG CAA GCA GTC ATT GGC TCA GCC-3′
M294C 5′-GTG GGA GCT GTC ATC TGC CCA CAC AAC ATG TAC-3′
M294Q 5′-GTG GGA GCT GTC ATC CAG CCA CAC AAC ATG TAC-3′
N472Q 5′-G ATG AAT GAC TTT CTG CAG GTT CTA CAG AGC TTA C-3′
N472A 5′-G ATG AAT GAC TTT CTG CAG GTT CTA CAG AGC TTA C-3′





Table 1. Oligonucleotides used for site-directed mutagenesis or final product sequencing. Mutated triplet is 
shown in bold, while the substituted amino acids from the Wt hDMT1 cDNA sequence are underlined. IRES 
primers were used to sequence pIRES2-DsRed clones, while M13 primers were used to sequence Pol1 clones.
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Scintillation and Luminescence Counter (PerkinElmer). Counts per minute (cpm) were determined for each well 




Influx rate count well cpm substrate pM
initial total counts cpm L uptake time
/ ( ) [ ] ( )
( / ) (min) (1)
To obtain kinetic parameters for Fe2+ and H+ saturation kinetics, a Michaelis-Menten equation was fit to the 
calculated influx rates.
Radiotracer uptake in X. laevis oocytes was measured over 10 min, with up to 15 micro-injected oocytes per 
condition in 300 µL transport medium (100 mM NaCl, 2 mM KCl, 1 mM CaCl2∙2 H2O, 1 mM MgCl∙6 H2O, 5 mM 
HEPES and 5 m MES, pH 5.5) containing the indicated concentration of non-radioactive Fe2+, 1 mM ascorbic 
acid and 0.5 µCi/mL 55Fe2+ iron. Once the incubation time had elapsed, oocytes were rinsed 3 times with ice-cold 
transport medium (pH 5.5) containing 250 µM non-radioactive Fe2+ and 1 mM ascorbic acid. Then, oocytes were 
solubilized with SDS 10% and the content of 55Fe2+ was determined by liquid scintillation counting. To determine 
background signal of the measurements, uptake by non-injected oocytes was determined for all the conditions 
tested. Influx rates were calculated as mentioned above.
Cadmium influx measured by real-time fluorescence imaging. HEK293 cells were seeded in clear 
bottom, black-well, poly-D-lysine coated 96-well plates and transfected as described above. 24 hours after trans-
fection, growth media was removed and cells were loaded with Calcium 5 fluorescent dye (Molecular Devices) in 
100 µL of uptake buffer (117 mM NaCl, 4.8 mM KCl, 1 mM MgCl, 10 mM glucose, 5 mM HEPES, 5 mM MES, pH 
7.4) at 37 °C for 1 hour. Measurements were performed at 37 °C using the FLIPR Tetra fluorescence microplate 
reader (Molecular Devices) as previously reported36. Cells were excited using a 470 to 495 nm LED module, and 
the emitted fluorescence signal was filtered with a 515 to 575 emission filter. Fluorescence signals were analyzed 
using the FLIPR Tetra software (ScreenWorks 3.1.2.002). A stable baseline was established for 50 seconds, then, 
50 µL of uptake buffer (pH 6.5) containing 2 µM Cd2+ was added and changes in fluorescence intensity were 
measured for 600 seconds. To measure the hDMT1 activity, the increase of the fluorescence intensity in response 
to cadmium was quantified by calculating the area under the curve.
Electrophysiology methods. The two-electrode voltage-clamp method was used to measure currents 
associated to the functional activity of wild type or mutant DMT1 expressed in X. laevis oocytes as previously 
described10, 28. Briefly, oocytes were placed in the recording chamber, which was continuously perfused with 
uptake buffer (117 mM NaCl, 4.8 mM KCl, 1 mM MgCl, 10 mM glucose, 5 mM HEPES, 5 mM MES, pH 7.4), and 
oocytes were impaled with two glass micro-electrodes filled with 3 mM KCl (resistance between 0.2 and 2 mΩ). 
Voltage-clamp experiments were performed according to two different protocols: (i) Oocytes were clamped at 
the holding potential (Vh = −50 mV), and step-changes in membrane potential (Vm) were applied from +50 
to −150 mV (in increments of 20 mV) each for a duration of 200 ms, before and after the addition of Fe2+. 
Steady-state currents were obtained by averaging the points over the middle point of the trace (10 ms) at each Vm 
step. Substrate-induced currents were determined as the difference between the steady-state currents measured 
in the absence and presence of Fe2+. (ii) Pre-steady state currents were recorded in the absence of Fe2+ using a 
modified version of protocol (i), in which the voltage steps were applied from + 90 to −110 mV. In both cases, 
currents were measured with an OC-725 amplifier (Warner Instruments), low-pass filtered at 500 Hz, digitized at 
5 kHz with a Digidata 1440 data acquisition system and captured using pClamp 10 software (Axon Instruments).
The following 4-parameter Hill function was fit to substrate-induced current data, for which I is the evoked 
current, Imax is the derived maximum current, S is the concentration of substrate (H+ or Fe2+), KS0.5 is the sub-
strate concentration at which current was half-maximal, nH is the Hill coefficient for S, and iU describes the 
Fe2+-evoked current in the absence of H+.
= +
+.
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Following step-changes of the above described protocol (ii), pre-steady state currents were obtained. These 
currents had to be isolated from capacitive transient currents and steady-state currents by the previously 
described fitted method10, 28, 61. Obtained pre-steady state currents were then integrated with time to determine 
charge movements (Q) and these were used to fit the following Boltzmann function for which maximal charge 
Qmax = Qdep − Qhyp (Qdep and Qhyp represent the charge at depolarizing and hyperpolarizing limits, respectively), 
V0.5 is the Vm at the midpoint of charge transfer, z is the apparent valence of the movable charge, and F, R and T 
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1
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max m 0 5
Statistics. Except for representative experiments, results are expressed as mean values ± standard deviation 
(SD). Difference between independent groups were assessed by unpaired Student’s test or Mann-Whitney U test, 
depending on the fit of the dependent variables to the normal distribution assessed by Kolmogorov-Smirnov and 
Shapiro-Wilk tests (for experiments with less than 50 samples). All statistical tests were performed using the IBM 
SPSS statistics 20 software. Significance level was set at p < 0.05.
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